Mk. Reeveshoche et al., CONTINUOUS VERSUS BILEVEL POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP-APNEA, American journal of respiratory and critical care medicine, 151(2), 1995, pp. 443-449
Citations number
16
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
Recent objective studies demonstrate relatively low hours of nightly u
se during nasal continuous positive airway pressure (CPAP) therapy for
obstructive sleep apnea (OSA). Patients frequently complain of dyspne
a or discomfort during CPAP use, especially during expiration (against
the continuous pressure), which may be a reason for the tow hours of
use. We hypothesized that with decreased expiratory pressure, hours of
nightly use would increase. Therefore, we randomized 83 OSA patients
to receive either continuous or bilevel positive airway pressure when
expiratory pressure is lower. To document objectively the effective us
e of either therapy, we built and installed elapsed-time and mask pres
sure sensors in the patients' positive airway pressure units. A total
of 62 patients were evaluable and followed for 1 yr. Of these, 26 rece
ived bilevel and 36 CPAP pressures. The machine timers measured accumu
lated ''machine-on'' time, and the mask pressure sensor recorded the t
otal time in which the mask pressure was within 2 cm H2O of the effect
ive pressure (pressure shown to eliminate 95% of the obstructive apnea
s during a full night of polysomnography). The mean machine timer hour
s of CPAP were 5.0 +/- 0.19 SEM and 4.9 +/- 0.23 SEM during bilevel th
erapy (p NS) over a 12-mo period. The pressures required during CPAP o
r bilevel therapy were not different between high and low hourly users
. Effective use, the percentage of time that the machine was running a
nd the prescribed pressure was being delivered, was 80% in CPAP and 82
% in the bilevel users (p NS). Both groups had equal complaints with r
egard to mask discomfort, machine noise, and nasal stuffiness. In conc
lusion, no difference in average hours of use during 12 mo of CPAP and
bilevel therapy was identified in the OSA patients studied.